A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)
- Status
- TERMINATED
- Phase
- PHASE2
5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
- Status
- UNKNOWN
- Phase
- PHASE3
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Bortezomib in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
- Status
- COMPLETED
- Phase
- PHASE2
Proton Therapy and Bevacizumab for Primary Liver Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- NA
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2